Ogilvie's syndrome
- 1 April 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 38 (4) , 424-427
- https://doi.org/10.1007/bf02054234
Abstract
This study was designed to determine the value of intravenous neostigmine in achieving adequate colonic decompression in patients with Ogilvie's syndrome. A prospective study was undertaken in 12 consecutive patients (median age, 60 (range, 38-98) years) with contrast enema-proven Ogilvie's syndrome (median duration, four (range, two-nine) days) Satisfactory clinical decompression of large bowel distention was attained in 11 patients, although one required colectomy for subsequent recurrence and ischemia. These results support the theory that many cases of Ogilvie's syndrome are the result of excessive large bowel parasympathetic suppression rather than sympathetic overactivity.Keywords
This publication has 8 references indexed in Scilit:
- Parasympathomimetic decompression of acute colonic pseudo-obstructionThe Lancet, 1993
- Prokinetic agents for lower gastrointestinal motility disordersDiseases of the Colon & Rectum, 1993
- Acute colonic pseudo-obstructionThe Lancet, 1993
- Acute colonic pseudo-obstructionBritish Journal of Surgery, 1992
- Acute pseudo-obstruction of the colon (Ogilvie's syndrome)Diseases of the Colon & Rectum, 1986
- Prevention of neostigmine‐induced colonic activityAnaesthesia, 1984
- Glycopyrrolate and the bowelAnaesthesia, 1984
- Large-intestine Colic due to Sympathetic DeprivationBMJ, 1948